Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group

2020/10/31 by Henrik Rüffert, Börge Bastian, Diana Bendixen +35 · 24 citations
Engineering · Medicine · #Ultrasound and Hyperthermia Applications #Inhalation and Respiratory Drug Delivery #Airway Management and Intubation Techniques

paper · doi:10.1016/j.bja.2020.09.029

Citations

• European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility

Cited by

• Recognition and management of a malignant hyperthermia crisis: updated 2024 guideline from the European Malignant Hyperthermia Group
• Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient. [europepmc]
• Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients. [europepmc]
• Remimazolam in a Pediatric Patient With a Suspected Family History of Malignant Hyperthermia. [europepmc]
• Malignant Hyperthermia in PICU-From Diagnosis to Treatment in the Light of Up-to-Date Knowledge. [europepmc]
• Clinical Features of Suspected Malignant Hyperthermia in China from 2015 to 2020: A Retrospective Study from China Malignant Hyperthermia Emergency Assistance Group. [europepmc]
• The Knowledge Profile, Competence and Pending Problems of Chinese Anesthesiologists in Dealing with Malignant Hyperthermia: A Cross-Sectional Survey. [europepmc]
• Free-living core body temperature monitoring using a wrist-worn sensor after COVID-19 booster vaccination: a pilot study. [europepmc]
• Suspected malignant hyperthermia in a young Chinese patient undergoing a micro varicocelectomy surgery. [europepmc]
• Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia. [europepmc]
• Real Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review. [europepmc]
• Remimazolam-based total intravenous anesthesia in a patient with a confirmed diagnosis of malignant hyperthermia: a case report. [europepmc]
• Successful sedation with remimazolam and alfentanil in a child susceptible to malignant hyperthermia: a case report. [europepmc]
• Anabolic androgenic steroids and illicit drugs as potential modulating factors in malignant hyperthermia: a case series. [europepmc]
• The Effectiveness of a Mobile National Remote Emergency System for Malignant Hyperthermia in China: Retrospective Pre-Post Implementation Study. [europepmc]
• National insights on malignant hyperthermia: a SIAARTI survey on clinical practices, preparedness, and future directions. [europepmc]
• Genetic Testing for Malignant Hyperthermia Susceptibility-Threading the Needle in the Haystack. [europepmc]
• Remimazolam as an Adjunct to General Anesthesia During Surgery for Congenital Heart Disease in a Pediatric Patient With a Family History of Malignant Hyperthermia. [europepmc]
• JSA guideline for management of malignant hyperthermia in 2025. [europepmc]
• A Proposed North American Approach for Genetic Testing of Individuals at Risk for Malignant Hyperthermia. [europepmc]
• Evaluation of clinically relevant sevoflurane concentrations in the development of malignant hyperthermia in an Ryr1 mutant mouse model. [europepmc]
• A proposed North American approach for genetic testing of individuals at risk for malignant hyperthermia. [europepmc]
• Anesthesia Management in a Patient With a History of Fulminant Malignant Hyperthermia and a Homozygous RYR1 p.Arg530His Variant Undergoing Laparoscopic Surgery: A Case Report. [europepmc]
• Effects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived from Patients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants [europepmc]